Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity

Urine neopterin may have potential as a biomarker for memory decline in Down syndrome, and could potentially also help to track progression of mild cognitive impairment (MCI) to Alzheimer's disease in other high risk populations.